PL365886A1 - Use of il-8 receptor antagonists in the treatment of virus infections - Google Patents

Use of il-8 receptor antagonists in the treatment of virus infections

Info

Publication number: PL365886A1
Authority: PL; Poland
Prior art keywords: treatment; receptor antagonists; virus infections; infections; virus
Prior art date: 2000-07-18

Application number

PL01365886A

Other languages

Polish (pl)

Inventor

Susan B. Dillon

Ruth Tal-Singer

Original Assignee

Smithkline Beecham Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-18

Filing date

2001-07-16

Publication date

2005-01-10

2001-07-16 Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation

2005-01-10 Publication of PL365886A1 publication Critical patent/PL365886A1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

PL01365886A 2000-07-18 2001-07-16 Use of il-8 receptor antagonists in the treatment of virus infections PL365886A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US21905300P	2000-07-18	2000-07-18

Publications (1)

Publication Number	Publication Date
PL365886A1 true PL365886A1 (en)	2005-01-10

Family

ID=22817645

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL01365886A PL365886A1 (en)	2000-07-18	2001-07-16	Use of il-8 receptor antagonists in the treatment of virus infections

Country Status (17)

Country	Link
EP (1)	EP1307190A4 (en)
JP (1)	JP2004509852A (en)
KR (1)	KR20030019587A (en)
CN (1)	CN1449285A (en)
AR (1)	AR033830A1 (en)
AU (1)	AU2001273497A1 (en)
BR (1)	BR0112603A (en)
CA (1)	CA2418162A1 (en)
CZ (1)	CZ2003132A3 (en)
HU (1)	HUP0300754A3 (en)
IL (1)	IL153921A0 (en)
MX (1)	MXPA03000500A (en)
NO (1)	NO20030201L (en)
NZ (1)	NZ523659A (en)
PL (1)	PL365886A1 (en)
WO (1)	WO2002005814A1 (en)
ZA (1)	ZA200300474B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1819329A2 (en) *	2004-08-04	2007-08-22	Schering Corporation	Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases
JP2017515840A (en) *	2014-05-12	2017-06-15	グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅＩｎｔｅｌｌｅｃｔｕａｌＰｒｏｐｅｒｔｙ（Ｎｏ．２）Ｌｉｍｉｔｅｄ	Pharmaceutical composition comprising tanilyxin for treating infectious diseases
EP3884932A1 (en) *	2020-03-26	2021-09-29	Dompe' Farmaceutici S.P.A.	Cxcl8 inhibitors for use in the treatment of covid-19
CA3176715A1 (en) *	2020-03-26	2021-09-30	Dompe' Farmaceutici Spa	Cxcl8 inhibitors for use in the treatment of covid-19
EP4008325A1 (en) *	2020-12-02	2022-06-08	Dompe' Farmaceutici S.P.A.	Cxcl8 inhibitors for use in the treatment of covid-19

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5547979A (en) *	1992-03-30	1996-08-20	Smithkline Beecham	TNF inhibition
WO1996005836A2 (en) *	1994-08-25	1996-02-29	Medical University Of South Carolina	Methods of treating cold symptoms using pentoxifylline
EP0809492A4 (en) *	1995-02-17	2007-01-24	Smithkline Beecham Corp	Il-8 receptor antagonists
SE9802729D0 (en) *	1998-08-13	1998-08-13	Astra Pharma Prod	Novel Compounds
SE9802937D0 (en) *	1998-09-01	1998-09-01	Astra Pharma Prod	Novel compounds

2001
- 2001-07-16 PL PL01365886A patent/PL365886A1/en not_active Application Discontinuation
- 2001-07-16 AU AU2001273497A patent/AU2001273497A1/en not_active Abandoned
- 2001-07-16 IL IL15392101A patent/IL153921A0/en unknown
- 2001-07-16 JP JP2002511746A patent/JP2004509852A/en not_active Withdrawn
- 2001-07-16 CN CN01813095A patent/CN1449285A/en active Pending
- 2001-07-16 CZ CZ2003132A patent/CZ2003132A3/en unknown
- 2001-07-16 KR KR10-2003-7000717A patent/KR20030019587A/en not_active Withdrawn
- 2001-07-16 NZ NZ523659A patent/NZ523659A/en unknown
- 2001-07-16 EP EP01952777A patent/EP1307190A4/en not_active Withdrawn
- 2001-07-16 HU HU0300754A patent/HUP0300754A3/en unknown
- 2001-07-16 BR BR0112603-2A patent/BR0112603A/en not_active IP Right Cessation
- 2001-07-16 AR ARP010103395A patent/AR033830A1/en not_active Application Discontinuation
- 2001-07-16 MX MXPA03000500A patent/MXPA03000500A/en unknown
- 2001-07-16 CA CA002418162A patent/CA2418162A1/en not_active Abandoned
- 2001-07-16 WO PCT/US2001/022328 patent/WO2002005814A1/en not_active Ceased
2003
- 2003-01-15 NO NO20030201A patent/NO20030201L/en not_active Application Discontinuation
- 2003-01-17 ZA ZA200300474A patent/ZA200300474B/en unknown

Also Published As

Publication number	Publication date
NO20030201D0 (en)	2003-01-15
CN1449285A (en)	2003-10-15
NO20030201L (en)	2003-03-17
EP1307190A1 (en)	2003-05-07
NZ523659A (en)	2006-01-27
CA2418162A1 (en)	2002-01-24
ZA200300474B (en)	2004-08-17
MXPA03000500A (en)	2003-06-24
IL153921A0 (en)	2003-07-31
WO2002005814A1 (en)	2002-01-24
EP1307190A4 (en)	2007-08-22
CZ2003132A3 (en)	2003-09-17
BR0112603A (en)	2004-08-24
KR20030019587A (en)	2003-03-06
HUP0300754A3 (en)	2009-03-02
AR033830A1 (en)	2004-01-07
HUP0300754A2 (en)	2003-08-28
JP2004509852A (en)	2004-04-02
AU2001273497A1 (en)	2002-01-30

Publication	Publication Date	Title
EE05507B1 (en)	2012-02-15	Use of rosuvastatin ZD4522) in the treatment of heterosgococcal family h percolesterolemia
MXPA03004915A (en)	2003-09-05	Mch antagonists and their use in the treatment of obesity.
MXPA03008501A (en)	2003-12-08	Mch antagonists and their use in the treatment of obesity.
HUS1300015I1 (en)	2021-05-28	Antibodies to human il-1beta
EE200200484A (en)	2004-04-15	Low dose entecavir preparation and its use
IL141034A0 (en)	2002-02-10	Uracil compounds and use thereof
PT1317485E (en)	2011-07-06	Myostatin antagonists and uses thereof
DE60033055D1 (en)	2007-03-08	LUMBAR TREATMENT DEVICE
MXPA03004439A (en)	2003-08-19	Aminothiazoles and their use as adenosine receptor antagonists.
HUP0301308A3 (en)	2010-01-28	Human papilloma virus treatment
DE60026949D1 (en)	2006-05-18	Interconnects
IL152700A0 (en)	2003-06-24	Substituted 1-aminoalkyl-lactams and their use as muscarinc receptor antagonists
IL153708A0 (en)	2003-07-06	Benzimidazole derivatives, preparation and therapeutic use thereof
DE60102506D1 (en)	2004-05-06	Interconnects
AR027945A1 (en)	2003-04-16	USE OF PRAMIPEXOL IN THE TREATMENT OF ADDICTION DISORDERS
HUP0401756A3 (en)	2005-06-28	Substituted benzimidazole compounds and their use
HUP0300599A3 (en)	2003-09-29	Il-8 receptor antagonists, pharmaceutical compositions containing them and their use
AU9279601A (en)	2002-04-08	Compounds and methods for use thereof in the treatment of cancer or viral infections
PT1556382E (en)	2008-07-09	3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof
GB0105613D0 (en)	2001-04-25	Pharmaceutically effective compounds and their use
DE60100973D1 (en)	2003-11-20	Interconnects
IL153921A0 (en)	2003-07-31	Use of il-8 receptor antagonists in the treatment of virus infections
HUP0300470A3 (en)	2005-05-30	Il-8 receptor antagonists, pharmaceutical compositions containing them and their use
EP1322319A4 (en)	2005-08-31	Use of il-8 protein modulators in the treatment of viral infections
ZA200403530B (en)	2005-07-28	Chemokine receptor antagonists and methods of use thereof.

Legal Events

Date	Code	Title	Description
2009-06-30	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)